Related Experiment Video
Updated: Apr 16, 2026

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Retinal complications in diabetes mellitus: importance of screening and management
1University Clinic of Eye Diseases, Medical Faculty, Ss. Cyril and Methodius University, Skopje, R. Macedonia.
Introduction:
Diabetic retinal complications are the most common cause of reduced visual acuity in persons aged 25 to 75 years. However, vision loss can be prevented or delayed if the changes are seen on time.
Aim:
By analyzing literature data to create an algorithm for careful follow-up of diabetic patients, which would prevent progression of the changes and development of conditions leading to blindness. At the same time, this paper presents certain changes of the eye fundus and mode of their treatment.
Material And Method:
Analysis of studies published on diabetic retinopathy and screening conducted in developed countries, with creating an algorithm for follow-up of diabetic retinal changes and their management.
Conclusion:
Timely detection and treatment of diabetic retinopathy with application of protocols in developed countries as well as parallel correction of systemic risk factors for progression of diabetic retinopathy will reduce the possibility of visual impairment in diabetics due to retinal complications. At the same time expenditures related to more complicated and less effective surgical procedures will be reduced along with the societal concern.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Photoreceptors and Visual Pathways
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

